- Telehealth Visits
- Insurance plan information
Christopher Dowd, MD
Neuroradiology • Diagnostic Radiology- Telehealth Visits
- Insurance plan information
Christopher Dowd, MD
Neuroradiology • Diagnostic Radiology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. Christopher Dowd is an expert in neurointerventional radiology, the minimally invasive diagnosis and treatment of disorders involving blood vessels of the brain and spine. He has special interests in treating brain aneurysms and vascular malformations using endovascular techniques.
After receiving his undergraduate degree in biology from Harvard University, Dowd earned his medical degree at the University of Virginia. He completed a residency in diagnostic radiology at University of California, San Diego, and fellowships in neuroradiology and interventional radiology at UCSF, where he joined the faculty in 1987.
Dowd is the recipient of numerous prestigious awards, including the Clinical Teacher of the Year award from the UCSF Department of Dermatology and Elliot Lasser Award from the UCSD Department of Radiology.
Education & training
Board certification
- Neuroradiology, American Board of Radiology
- Diagnostic Radiology, American Board of Radiology
Fellowship
- Interventional Radiology, UCSF Graduate Medical Education
Residency
- Radiology, General, UCSF Graduate Medical Education
- Internal Medicine, University of California - San Diego
Degree
- MD, University of Virginia
My expertise
Specialties
- Neuroradiology
- Diagnostic Radiology
Clinical Trials query: q=health_gateway_id_ss%3A%28%22490%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%22490%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.